Recent reviews have assessed the potential utility of TRAIL as an anti-tumor agent [35], and the delivery of TRAIL to tumors using alginate-based nanocomposites [50], carbon nanotubes [51], and other inorganic and organic nanoparticles has also been explored [52, 53]. The gene discussed is TNFSF10; the disease is neoplasm.